AtriCure (ATRC) News Today $35.03 -0.28 (-0.79%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period AtriCure, Inc. (NASDAQ:ATRC) Sees Significant Decrease in Short InterestAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 2,250,000 shares, a decline of 31.6% from the October 15th total of 3,290,000 shares. Based on an average trading volume of 586,600 shares, the days-to-cover ratio is currently 3.8 days.November 14 at 5:28 AM | marketbeat.comAtriCure to Participate in the Stifel 2024 Healthcare ConferenceNovember 8, 2024 | finance.yahoo.comEmerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC)Emerald Advisers LLC increased its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 389,836 shares of the medical device company's stock afteNovember 3, 2024 | marketbeat.comUS$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These ResultsNovember 3, 2024 | finance.yahoo.comAtriCure Third Quarter 2024 Earnings: Beats ExpectationsNovember 1, 2024 | finance.yahoo.comAtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market ChallengesOctober 31, 2024 | finance.yahoo.comOppenheimer Sticks to Its Buy Rating for Atricure (ATRC)October 31, 2024 | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysCanaccord Genuity Group increased their target price on shares of AtriCure from $49.00 to $53.00 and gave the stock a "buy" rating in a research note on Wednesday.October 30, 2024 | marketbeat.comAtriCure price target raised to $36 from $32 at OppenheimerOctober 30, 2024 | msn.comAtriCure (NASDAQ:ATRC) Posts Quarterly Earnings ResultsAtriCure (NASDAQ:ATRC - Get Free Report) issued its earnings results on Tuesday. The medical device company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.02. The company had revenue of $115.91 million during the quarter, compared to analysts' expectations of $112.23 million. AtriCure had a negative net margin of 9.33% and a negative return on equity of 8.39%. The business's revenue for the quarter was up 17.9% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.20) EPS.October 30, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Shares Gap Up After Earnings BeatAtriCure (NASDAQ:ATRC) Shares Gap Up Following Better-Than-Expected EarningsOctober 30, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest UpdateAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 3,290,000 shares, a decline of 8.4% from the September 30th total of 3,590,000 shares. Based on an average daily volume of 622,900 shares, the days-to-cover ratio is currently 5.3 days.October 30, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Quotes, Forecast and News SummaryOctober 30, 2024 | benzinga.comAtriCure’s Strong Growth and Strategic Initiatives Earn Buy Rating from Analyst Daniel StauderOctober 30, 2024 | markets.businessinsider.comAtriCure, Inc. (ATRC) Q3 2024 Earnings Call TranscriptOctober 30, 2024 | seekingalpha.comAtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings GuidanceAtriCure (NASDAQ:ATRC) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.800--0.740 for the period, compared to the consensus estimate of -0.790. The company also issued revenue guidance of $459.0 millionillion-$462.0 millionillion, compared to the consensus estimate of $458.1 millionillion.October 29, 2024 | marketbeat.comAtriCure Reports Third Quarter 2024 Financial ResultsOctober 29, 2024 | businesswire.comAssenagon Asset Management S.A. Has $6.43 Million Position in AtriCure, Inc. (NASDAQ:ATRC)Assenagon Asset Management S.A. boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 151.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 229,130 shares of the medical device company's stock afteOctober 29, 2024 | marketbeat.comAtriCure to Participate in the UBS Global Healthcare ConferenceOctober 28, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Buy" from BrokeragesShares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have been given a consensus rating of "Buy" by the nine brokerages that are covering the firm, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average twelve-month price objective among broOctober 26, 2024 | marketbeat.comAtriCure (ATRC) Scheduled to Post Earnings on TuesdayAtriCure (NASDAQ:ATRC) will be releasing earnings after the market closes on Tuesday, October 29, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633724)October 22, 2024 | marketbeat.comSG Americas Securities LLC Makes New $488,000 Investment in AtriCure, Inc. (NASDAQ:ATRC)SG Americas Securities LLC bought a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund bought 17,393 shares of the medical device company's stock, valued at approximately $488,000. Several other institOctober 17, 2024 | marketbeat.comAtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain ManagementOctober 15, 2024 | finance.yahoo.comShareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years agoOctober 13, 2024 | uk.finance.yahoo.comAtriCure to Announce Third Quarter 2024 Financial ResultsOctober 8, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Dimensional Fund Advisors LPDimensional Fund Advisors LP cut its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 28.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 705,699 shares of the medical device company's stock after selling 274,740 shares during the period. DiOctober 6, 2024 | marketbeat.comMillennium Management LLC Has $21.69 Million Stake in AtriCure, Inc. (NASDAQ:ATRC)Millennium Management LLC increased its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 132.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 952,765 shares of the medical dOctober 5, 2024 | marketbeat.comAtriCure Receives CE-Mark for the EnCompass® ClampOctober 1, 2024 | finance.yahoo.comSquarepoint Ops LLC Buys 113,301 Shares of AtriCure, Inc. (NASDAQ:ATRC)Squarepoint Ops LLC raised its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 99.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 226,876 shares of the medical device company's stock after acquiring an additional 113,301October 1, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Receives Consensus Recommendation of "Buy" from AnalystsAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has been given a consensus rating of "Buy" by the nine ratings firms that are presently covering the stock, Marketbeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective amOctober 1, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Marshall Wace LLPMarshall Wace LLP lowered its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 53.4% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 447,941 shares of the medical device company's stock after selling 513,September 29, 2024 | marketbeat.comCanada Pension Plan Investment Board Raises Holdings in AtriCure, Inc. (NASDAQ:ATRC)Canada Pension Plan Investment Board raised its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 187.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 110,669 shares of the medical deviceSeptember 27, 2024 | marketbeat.comFirst Light Asset Management LLC Grows Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)First Light Asset Management LLC raised its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 42.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,964,703 shares of the medical device coSeptember 24, 2024 | marketbeat.comHood River Capital Management LLC Makes New Investment in AtriCure, Inc. (NASDAQ:ATRC)Hood River Capital Management LLC acquired a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,775,243 shares of the medical device compSeptember 23, 2024 | marketbeat.comHere’s Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC)September 18, 2024 | msn.comEmerald Advisers LLC Reduces Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Emerald Advisers LLC reduced its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 22.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 351,415 shares of the medical device company's stockSeptember 8, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Given Average Recommendation of "Buy" by AnalystsAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has received a consensus rating of "Buy" from the nine analysts that are currently covering the company, MarketBeat Ratings reports. Nine research analysts have rated the stock with a buy rating. The average twelve-month price target among brokeragesSeptember 6, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Rating Upgraded by StockNews.comStockNews.com upgraded AtriCure from a "sell" rating to a "hold" rating in a research note on Wednesday.September 4, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 17.0% in AugustAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 3,640,000 shares, a growth of 17.0% from the July 31st total of 3,110,000 shares. Based on an average trading volume of 888,500 shares, the days-to-cover ratio is presently 4.1 days.August 31, 2024 | marketbeat.comPanagora Asset Management Inc. Has $7.05 Million Stake in AtriCure, Inc. (NASDAQ:ATRC)Panagora Asset Management Inc. lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 8.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 309,547 shares of the medical device compaAugust 31, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Trading Up 4.1%AtriCure (NASDAQ:ATRC) Stock Price Up 4.1%August 30, 2024 | marketbeat.comStockNews.com Lowers AtriCure (NASDAQ:ATRC) to SellStockNews.com lowered AtriCure from a "hold" rating to a "sell" rating in a report on Tuesday.August 27, 2024 | marketbeat.comAtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ DeviceAugust 27, 2024 | finance.yahoo.comAtriCure (NASDAQ:ATRC) Stock Price Up 3.2%AtriCure (NASDAQ:ATRC) Trading 3.2% HigherAugust 22, 2024 | marketbeat.comAtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial FibrillationAugust 22, 2024 | finance.yahoo.comAssenagon Asset Management S.A. Has $2.07 Million Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Assenagon Asset Management S.A. decreased its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 79.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 91,084 shares of the medical device company's stock aAugust 21, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Director Maggie Yuen Sells 3,500 SharesAugust 20, 2024 | insidertrades.comAtriCure leadership explains $45M investment in Greater Cincinnati HQAugust 19, 2024 | bizjournals.comMaggie Yuen Sells 3,500 Shares of AtriCure, Inc. (NASDAQ:ATRC) StockAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) Director Maggie Yuen sold 3,500 shares of the company's stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $24.07, for a total value of $84,245.00. Following the sale, the director now owns 8,970 shares in the company, valued at approximately $215,907.90. The sale was disclosed in a filing with the SEC, which can be accessed through this link.August 19, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 14.3% in JulyAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 3,110,000 shares, a drop of 14.3% from the July 15th total of 3,630,000 shares. Based on an average trading volume of 889,800 shares, the days-to-cover ratio is presently 3.5 days.August 17, 2024 | marketbeat.com Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide ATRC Media Mentions By Week ATRC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼1.590.55▲Average Medical News Sentiment ATRC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼34▲ATRC Articles Average Week Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SILK News Today ATRI News Today LUNG News Today INO News Today ITGR News Today IART News Today ATEC News Today OFIX News Today SRDX News Today ANGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATRC Stock Alerts